EUVIMEDEUVIMED entdecken
Crossref

Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group

Masuho Saburi, Kumi Oshima, Kuniko Takano, Yoshitaka Inoue, Kaito Harada, Naoyuki Uchida, Takahiro Fukuda, Noriko Doki, Kazuhiro Ikegame, Yayoi Matsuo, Yuta Katayama, Yukiyasu Ozawa und 10 weitere

Annals of Hematology · 2023

DOI: 10.1007/s00277-023-05320-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2023. Verfasst von Masuho Saburi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oita Prefectural Hospital, 2-8-1 Bunyo, Oita City, Oita, 870-8511, Japan. masuho-saburi@oita-u.ac.jp. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Hematopoietic Stem Cell Transplantation, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stenotrophomonas maltophilia (S. maltophilia) is an aerobic nonfermenting Gram-negative bacillus widely distributed in the environment that has inherent multidrug resistance to beta-lactam and carbapenem antibiotics. S. maltophilia infection (SMI) is known as an important fatal complication following allogeneic hematopoietic stem cell transplantation (HSCT), but its clinical characteristics have not been well clarified. A retrospective study to identify the incidence, risk factors, and outcomes of SMI after allogeneic HSCT was performed using the database of the Japanese nationwide registry, including 29,052 patients who received allogeneic HSCT in Japan between January 2007 and December 2016. A total of 665 patients developed SMI (sepsis/septic shock, 432; pneumonia, 171; other, 62). The cumulative incidence of SMI at 100 days after HSCT was 2.2%. Among risk factors identified for SMI (age ≥ 50 years, male, performance status 2-4, cord blood transplantation [CBT], myeloablative conditioning, Hematopoietic Cell Transplant-Comorbidity Index [HCT-CI] score 1-2, HCT-CI score ≥ 3, and active infectious disease at HSCT), CBT was the strongest risk factor (hazard ratio, 2.89; 95%CI, 1.94-4.32; p < 0.001). The survival rate at day 30 after SMI was 45.7%, and SMI before neutrophil engraftment was significantly associated with poor survival (survival rate 30 days after SMI, 40.1% and 53.8% in patients with SMI before and after engraftment, respectively; p = 0.002). SMI is rare after allogeneic HSCT, but its prognosis is extremely poor. CBT was a strong risk factor for SMI, and its development prior to neutrophil engraftment was associated with poor survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stenotrophomonas maltophiliaHematopoietic Stem Cell TransplantationGram-Negative Bacterial InfectionsHumansMaleMiddle AgedRetrospective StudiesGram-Negative BacteriaRisk Factors

Stichwörter der Autor:innen

Allogeneic Hematopoietic Stem Cell transplantationCord blood transplantationPneumoniaSepsisStenotrophomonas maltophilia

Autor:innen und Institutionen

  • Department of Hematology, Oita Prefectural Hospital, 2-8-1 Bunyo, Oita City, Oita, 870-8511, Japan. masuho-saburi@oita-u.ac.jp.
  • Department of Hematology, Jyoban Hospital, Tokiwa Foundation, Fukushima, Japan.
  • Department of Hematology, Oita University Hospital, Oita, Japan.
  • Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan.
  • Department of Hematology and Oncology, Tokai University, Isehara, Japan.
  • Department of Hematology, Toranomon Hospital, Tokyo, Japan.

Zitieren

APA

Saburi, M., Oshima, K., Takano, K., Inoue, Y., Harada, K., Uchida, N., Fukuda, T., Doki, N., Ikegame, K., Matsuo, Y., Katayama, Y., Ozawa, Y., Matsuoka, K. I., Kawakita, T., Mori, Y., Ara, T., Nakamae, H., Kimura, T., Kanda, Y., …, & Transplant Complications Working Group of the Japanese Society for Transplantation and Cellular Therapy (2023). Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group. Annals of Hematology. https://doi.org/10.1007/s00277-023-05320-4

Vancouver

Saburi M, Oshima K, Takano K, Inoue Y, Harada K, Uchida N, et al. Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group. Annals of Hematology. 2023. doi:10.1007/s00277-023-05320-4

BibTeX
@article{Saburi2023,
  author = {Saburi, Masuho and Oshima, Kumi and Takano, Kuniko and Inoue, Yoshitaka and Harada, Kaito and Uchida, Naoyuki and Fukuda, Takahiro and Doki, Noriko and Ikegame, Kazuhiro and Matsuo, Yayoi and Katayama, Yuta and Ozawa, Yukiyasu and Matsuoka, Ken-Ichi and Kawakita, Toshiro and Mori, Yasuo and Ara, Takahide and Nakamae, Hirohisa and Kimura, Takafumi and Kanda, Yoshinobu and Atsuta, Yoshiko and Ogata, Masao and Transplant Complications Working Group of the Japanese Society for Transplantation and Cellular Therapy, Transplant Complications Working Group of the Japanese Society for Transplantation and Cellular Therapy},
  title = {Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group},
  journal = {Annals of Hematology},
  year = {2023},
  doi = {10.1007/s00277-023-05320-4}
}
Kostenlos starten →